Evidence map›Paper›PMID 34789229›Full record

ArticleBMC public health2021

COVID-19 vaccination acceptance among Syrian population: a nationwide cross-sectional study.

Mosa Shibani, Mhd Amin Alzabibi, Abd El-Fattah Mouhandes, Tamim Alsuliman, Angie Mouki, Hlma Ismail, Shahd Alhayk, Ahmad Abdulateef Rmman, Marah Mansour, Marah Marrawi and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Human vaccines & immunotherapeutics · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 5 countries.

Mosa ShibaniFaculty of Medicine, Syrian Private University, Mazzeh Street, P.O. Box 36822, Damascus, Syrian Arab Republic. moosa.shibani@gmail.com.
Mhd Amin AlzabibiFaculty of Medicine, Syrian Private University, Mazzeh Street, P.O. Box 36822, Damascus, Syrian Arab Republic.
Abd El-Fattah MouhandesFaculty of Medicine, University of Aleppo, Aleppo, Syria.
Tamim AlsulimanHematology and Cell Therapy Department, Saint-Antoine Hospital, AP-HP Sorbonne University, Paris, France.
Angie MoukiFaculty of Pharmacy, Maykop State Technological University, Maykop, Russia.
Hlma IsmailFaculty of Medicine, Syrian Private University, Mazzeh Street, P.O. Box 36822, Damascus, Syrian Arab Republic.
Shahd AlhaykFaculty of Medicine, Syrian Private University, Mazzeh Street, P.O. Box 36822, Damascus, Syrian Arab Republic.
Ahmad Abdulateef RmmanFaculty of Medicine, Syrian Private University, Mazzeh Street, P.O. Box 36822, Damascus, Syrian Arab Republic.
Marah MansourFaculty of Medicine, Tartous university, Tartous, Syria.
Marah MarrawiDepartment of Statistics, Syrian Private University, Damascus, Syria.
Nawras AlhalabiFaculty of Medicine, Syrian Private University, Mazzeh Street, P.O. Box 36822, Damascus, Syrian Arab Republic.
Mhd Baraa HabibDepartment of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Mhd Kutaiba AlbuniDepartment of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Ahmad Al-MoujahedDepartment of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Bisher SawafDepartment of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Data Collection Group
Syrian Private University · SYUniversity of Aleppo · SYHamad Medical Corporation · QAMaikop State Technological University · RUSmith-Kettlewell Eye Research Institute · USSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere Acute Respiratory Syndrome Coronavirus 2 continues to spread globally and in the absence of an effective treatment, the vaccine remains the best hope for controlling this disease. In this study, we seek to find out the extent to which people in Syria accept the Corona vaccine and what are the factors that affect their decision.

methodsThis cross-sectional study was conducted in Syria during the period from January 3 to March 17, 2021. A structured self-administered questionnaire was distributed in two phases: The first phase included distributing the questionnaire as a Google Form on social media platforms. In the second phase, a paper version of the questionnaire was handed to patients, their companions, and workers in public hospitals. SPSS v.25 and R v.4.1.1 were used to analyze the data. Pearson Chi-square test and Logistic Regression were used to study the associations between categorical groups.

resultsOf 7531 respondents, 3505 (46.5%) were males and 4026 (53.5%) were females. 3124 (41.5%) were 18-24 years old. Healthcare workers were participants' main sources of information (50.9%), followed by Social Media users (46.3%). 2790 (37%) of the participant are willing to be vaccinated, and 2334 (31%) were uncertain about it. Fear of possible side effects was the main reason for the reluctance to take the vaccine 1615 (62.4%), followed by mistrust of the vaccine formula 1522 (58.8%). 2218 (29.5%) participants think COVID-19 poses a major risk to them personally. Vaccination intention was significantly associated with gender, residence, financial status, educational level, and geographic origin.

conclusionThis study showed very negatively important results. The study participants Vaccination acceptance rate is almost the lowest when compared to its peers. A Lot of efforts should be made to correct misinformation about the vaccine and answer all questions about it, especially with a health system that has been ravaged by war for 10 years.

Indexed as

COVID-19COVID-19 VaccinesAdolescentAdultCross-Sectional StudiesFemaleHumansMaleSARS-CoV-2SyriaVaccinationYoung AdultCOVID-19 VaccinesAcceptanceCOVID-19SARS-CoV-2SyriaVaccine

Identifiers

PMID34789229
PMCPMC8598277
OpenAlexW3213551615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.